Belpointe Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-193
Closed -$10.5K 3538
2023
Q1
$10.5K Hold
193
﹤0.01% 2689
2022
Q4
$12.1K Buy
+193
New +$12.8K ﹤0.01% 2514

Other funds holding AXNX

Belpointe Asset Management's AXNX Position: Q2 2023 in Review

Belpointe Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 193 shares — an estimated $10.5K sold.

Belpointe Asset Management first reported a position in AXNX in Q4 2022 and held it in 2 quarters. The position peaked at $12.1K in Q4 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

  • Belpointe Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Belpointe Asset Management sold 193 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $10.5K.
  • Belpointe Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2022 and held it in 2 quarters.
  • Belpointe Asset Management's Axonics, Inc. Common Stock position peaked at $12.1K in Q4 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Belpointe Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.